Takuya Komeno

1.4k total citations
49 papers, 595 citations indexed

About

Takuya Komeno is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Takuya Komeno has authored 49 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 17 papers in Pathology and Forensic Medicine and 16 papers in Oncology. Recurrent topics in Takuya Komeno's work include Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Multiple Myeloma Research and Treatments (9 papers). Takuya Komeno is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Multiple Myeloma Research and Treatments (9 papers). Takuya Komeno collaborates with scholars based in Japan, United States and Belgium. Takuya Komeno's co-authors include Toshiro Nagasawa, Yuichi Hasegawa, Haruhiko Ninomiya, Satoru Takahashi, Tsukasa Abe, Harumi Y. Mukai, Hiroshi Kojima, Kazumi Suzukawa, Mitsuo Hori and Takashi Kuroha and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Transplantation.

In The Last Decade

Takuya Komeno

45 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuya Komeno Japan 13 278 175 166 144 118 49 595
Silvana Capalbo Italy 15 289 1.0× 179 1.0× 271 1.6× 144 1.0× 143 1.2× 37 669
Kang Howson‐Jan Canada 12 404 1.5× 117 0.7× 189 1.1× 137 1.0× 154 1.3× 33 666
A. von Rohr Switzerland 13 154 0.6× 122 0.7× 275 1.7× 111 0.8× 204 1.7× 25 530
Tawfiq Henni France 12 201 0.7× 217 1.2× 272 1.6× 103 0.7× 326 2.8× 26 686
R. D. Brunning United States 12 252 0.9× 229 1.3× 194 1.2× 103 0.7× 151 1.3× 16 625
H van Kamp Netherlands 15 483 1.7× 159 0.9× 146 0.9× 266 1.8× 136 1.2× 25 883
D Samson United Kingdom 14 549 2.0× 169 1.0× 108 0.7× 213 1.5× 43 0.4× 23 684
Minami Yamada Japan 12 154 0.6× 104 0.6× 78 0.5× 77 0.5× 90 0.8× 24 369
Archrob Khuhapinant Thailand 11 209 0.8× 118 0.7× 261 1.6× 56 0.4× 201 1.7× 37 550
Serena Merante Italy 17 554 2.0× 89 0.5× 492 3.0× 131 0.9× 103 0.9× 40 828

Countries citing papers authored by Takuya Komeno

Since Specialization
Citations

This map shows the geographic impact of Takuya Komeno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Komeno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Komeno more than expected).

Fields of papers citing papers by Takuya Komeno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Komeno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Komeno. The network helps show where Takuya Komeno may publish in the future.

Co-authorship network of co-authors of Takuya Komeno

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Komeno. A scholar is included among the top collaborators of Takuya Komeno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Komeno. Takuya Komeno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iida, Shinsuke, Tohru Izumi, Takuya Komeno, et al.. (2021). A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma. International Journal of Clinical Oncology. 27(1). 224–233. 5 indexed citations
2.
Kunisawa, Susumu, Chikashi Yoshida, Masanori SEKI, et al.. (2019). Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study. International Journal of Clinical Oncology. 24(11). 1449–1458. 6 indexed citations
3.
4.
Ichinohe, Tatsuo, Yoshiaki Kuroda, Shinichiro Okamoto, et al.. (2015). A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial. Experimental Hematology and Oncology. 5(1). 11–11. 10 indexed citations
5.
Sekimoto, Miho, Yuichi Imanaka, K. Yoshihara, et al.. (2010). RISK-ADJUSTED ASSESSMENT OF FRESH FROZEN PLASMA AND ALBUMIN PRODUCT USE IN ACUTE-CARE HOSPITALS IN JAPAN: AN ANALYSIS USING ADMINISTRATIVE DATA. Japanese Journal of Transfusion and Cell Therapy. 56(5). 599–605. 1 indexed citations
6.
Sekimoto, Miho, Yuichi Imanaka, Hiromasa Sasaki, et al.. (2009). Risk-adjusted assessment of incidence and quantity of blood use in acute-care hospitals in Japan: an analysis using administrative data. Vox Sanguinis. 98(4). 538–546. 5 indexed citations
7.
Ohtani, Haruo, Takuya Komeno, M. Koizumi, et al.. (2008). Submassive hepatocellular necrosis associated with infiltration by peripheral T‐cell lymphoma of cytotoxic phenotype: Report of two cases. Pathology International. 58(2). 133–137. 4 indexed citations
8.
9.
Kojima, Hiroshi, Yuichi Hasegawa, Kazumi Suzukawa, et al.. (2004). Clinicopathological features and prognostic factors of Japanese patients with “peripheral T-cell lymphoma, unspecified” diagnosed according to the WHO classification. Leukemia Research. 28(12). 1287–1292. 22 indexed citations
10.
Kojima, Hiroshi, Harumi Y. Mukai, Atsushi Shinagawa, et al.. (2000). Clinicopathological analyses of 5 Japanese patients with CD56+ primary cutaneous lymphomas.. PubMed. 72(4). 477–83. 19 indexed citations
11.
Nomura, Keiko, Hirokazu Kanegane, Hajime Karasuyama, et al.. (2000). Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway.. PubMed. 96(2). 610–7. 71 indexed citations
12.
Hasegawa, Yoshinori, Takayuki Itoh, Takuya Komeno, et al.. (1999). Non-Hodgkin's Lymphoma Followed by Plasmacytoma, Both Arising in a Thyroid Gland with Hashimoto's Disease. Leukemia & lymphoma. 35(5-6). 613–618. 2 indexed citations
13.
Kojima, Hiroshi, Mitsuo Hori, Nobuo Nara, et al.. (1999). Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells. Experimental Hematology. 27(2). 259–265. 37 indexed citations
14.
Mukai, Harumi Y., Hiroshi Kojima, Kazumi Suzukawa, et al.. (1999). High-Dose Chemotherapy with Peripheral Blood Stem Cell Rescue in Blastoid Natural Killer Cell Lymphoma. Leukemia & lymphoma. 32(5-6). 583–588. 23 indexed citations
15.
Komeno, Takuya, Kazuo Todokoro, Kazumi Suzukawa, et al.. (1999). Immature megakaryocytes undergo apoptosis in the absence of thrombopoietin. Experimental Hematology. 27(1). 131–138. 22 indexed citations
16.
Kuroha, Takeshi, Satoru Takahashi, Takuya Komeno, et al.. (1998). Ablation of Nrf2 Function Does Not Increase the Erythroid or Megakaryocytic Cell Lineage Dysfunction Caused by p45 NF-E2 Gene Disruption. The Journal of Biochemistry. 123(3). 376–379. 33 indexed citations
17.
Suzukawa, Kazumi, N Mori, Harumi Y. Mukai, et al.. (1998). Anaplastic large-cell lymphoma of null-cell type with multiple bone involvement. Annals of Hematology. 77(6). 287–290. 12 indexed citations
18.
Shimizu, Seiichi, Shigeko Nishimura, Kazumi Suzukawa, et al.. (1998). Serum thrombopoietin level is mainly regulated by megakaryocyte mass rather than platelet mass in human subjects. British Journal of Haematology. 101(2). 242–244. 37 indexed citations
19.
Ito, Takayoshi, Koji Otani, Takuya Komeno, et al.. (1996). Chronic Neutrophilic Leukemia Associated with Monoclonal Gammopathy of Undetermined Significance. Acta Haematologica. 95(2). 140–143. 20 indexed citations
20.
Nagasawa, Toshiro, Yuichi Hasegawa, Takuya Komeno, et al.. (1995). Megakaryopoiesis in patients with cyclic thrombocytopenia. British Journal of Haematology. 91(1). 185–190. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvana Capalbo Breakdown of academic impact, for papers by Kang Howson‐Jan Breakdown of academic impact, for papers by A. von Rohr Breakdown of academic impact, for papers by Tawfiq Henni Breakdown of academic impact, for papers by R. D. Brunning Breakdown of academic impact, for papers by H van Kamp Breakdown of academic impact, for papers by D Samson Breakdown of academic impact, for papers by Minami Yamada Breakdown of academic impact, for papers by Archrob Khuhapinant Breakdown of academic impact, for papers by Serena Merante
Rankless by CCL
2026